Apheresis Market by Product Type, Distribution Channel, End User 2024-2032


MARKETRESEARCH

Uploaded on Sep 4, 2024

Category Business

According to the latest research report by IMARC Group, The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032. More Info:- https://www.imarcgroup.com/apheresis-market

Category Business

Comments

                     

Apheresis Market by Product Type, Distribution Channel, End User 2024-2032

Global Apheresis Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group IMARC Group is a g lobal management consul t ing f i rm that he lps the wor ld ’s most ambi t ious changemakers to create a las t ing impact . Across the s ix major cont inents and 100+ count r ies , we work a longside our bus iness par tners as one team wi th a common ambi t ion to achieve unparal le led resul ts , gain a compet i t ive edge, and t ransform indust r ies . IMARC Group excels in unders tanding i ts c l ients ’ bus iness pr ior i t ies and del iver ing ta i lored solut ions that dr ive meaningfu l outcomes. Our c l ient base spans over 3,000 organizat ions in the pr ivate, publ ic , and soc ia l sectors , ranging f rom high-growth s tar tups to For tune 500 companies. We prov ide a comprehensive sui te of market entry and expansion serv ices. Our of fer ings inc lude thorough market assessment , feas ib i l i ty s tudies, company incorporat ion ass is tance, fac tory setup suppor t , regulatory approvals and l icens ing navigat ion, branding, market ing and sales st rategies, compet i t ive landscape and benchmark ing analyses, pr ic ing and cost research, and procurement research. These serv ices are des igned to ass is t companies in evaluat ing market oppor tuni t ies , set t ing up new ent i t ies , navigat ing regulatory landscapes, boost ing brand v is ib i l i ty , analyz ing compet i tors, and opt imiz ing procurement s t rategies. A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " A p h e r e s is M a r k e t : G l o b a l In d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 - 2 0 3 2 , " t h e g l o b a l a p h e r e s i s m a r k e t s i z e r e a c h e d U S $ 2 .9 B i l l i o n i n 2 0 2 3 . F a c to rs A f fe c t in g th e G ro w th o f th e A p h e re s is In d u s t ry : Report I n c re a s in g P re v a le n c e o f C h ro n ic D is e a s e s : C h r o n i c d i s e a s e s , s u c h a s c a n c e r , a u t o i m m u n e d i s o r d e r s , a n d b l o o d - r e l a t e d c o n d i t i o n s , o f t e n r e q u i r e t h e r a p e u t i c i n t e r v e n t i o n s t h a t i n v o l v e r e m o v i n g h a r m f u l c o m p o n e n t s f r o m th e Highlight and b l o o d . A p h e r e s i s p r o c e d u r e s e n a b l e t h e s e l e c t i v e r e m o v a l o f t h e s e c o m p o n e n t s , t h e r e b y h e l p i n g t o m a n a g e t h e s y m p to m s a n d p r o g r e s s i o n o f t h e s e d i s e a s e s . A p h e r e s i s t e c h n i q u e s a r e a l s o u s e d f o r d i a g n o s t i c p u r p o s e s i n v a r i o u s c h r o n i c d i s e a s e s . Description A p h e r e s i s c a n a l s o h e l p i n a n a l y z i n g s p e c i f i c b l o o d c o m p o n e n t s o r i d e n t i f y i n g b i o m a r k e r s a s s o c i a t e d w i t h c e r t a i n c o n d i t i o n s , a i d i n g i n d i s e a s e d i a g n o s i s a n d m o n i t o r i n g . T e c h n o lo g ic a l A d v a n c em e n ts : I n n o v a t i o n s i n a p h e r e s i s t e c h n o l o g y a r e l e a d i n g t o t h e d e v e l o p m e n t o f m o r e e f f i c i e n t s y s t e m s f o r b l o o d c o m p o n e n t s e p a r a t i o n . T h e s e a d v a n c e m e n t s e n a b l e h i g h e r t h r o u g h p u t , s h o r t e r p r o c e d u r e t i m e s , a n d i n c r e a s e d c o l l e c t i o n y i e l d s , e n h a n c i n g t h e o v e r a l l e f f i c i e n c y o f a p h e r e s i s p r o c e d u r e s . Modern apheres is machines incorporate sophis t icated automat ion and cont ro l features that a l low for prec ise manipu la t ion of b lood components. Th is prec is ion ensures the accurate separat ion and co l lec t ion of spec i f ic b lood components , min imiz ing the r isk o f procedura l er rors and improving pat ient outcomes. Growing Demand for Blood Components: Report Apheres is procedures enable the se lec t ive co l lect ion of spec i f ic b lood components, such as p la te le ts , p lasma, and whi te b lood ce l ls (WBCs) . Highlight and These components have d iverse therapeut ic appl icat ions in t ransfus ion medic ine, hemato logy, oncology, and immunology. Description Plate le ts p lay a cruc ia l ro le in hemostas is and are f requent ly needed for pat ients w i th b leeding d isorders , undergoing surgery , or rece iv ing chemotherapy. Apheresis a l lows for the ef f ic ient co l lec t ion of p la te le ts f rom s ing le donors , meet ing the h igh demand for these b lood products . Request for a PDF sample of th is report : ht tps : / /www. imarcgroup.com/apheres is-market / requestsample Report Description Global Apheresis Market Trends: There is a growing emphasis on personal ized or precis ion medic ine approaches, which require ta i lored b lood component therapies co l lected through apheresis procedures to meet indiv idual pat ient needs. Apheresis procedures are f ind ing expanding therapeut ic appl icat ions beyond tradi t ional uses, inc lud ing the t reatment of neurological d isorders, organ t ransplantat ion, and immune-mediated d iseases, dr iv ing market d ivers i f icat ion. Ris ing awareness among heal thcare professionals and pat ients about the benef i ts of apheresis procedures is leading to h igher acceptance and ut i l izat ion of these techniques, contr ibut ing to the market growth. View Report TOC, Figures and Tables : https:/ /www.imarcgroup.com/apheresis-market Breakup by Component: • Plasma (P lasmapheresis) • Plate lets (P late letpheresis) • Leukocytes (Leukapheres is or Leukopheres is) • Lymphocytes (Lymphopheresis or Lymphapheres is) • RBC's (Erythropheres is) Report Segmentation Breakup by Product: • Devices • Disposables and Reagents • Software Breakup by Technology: • Centr i fugat ion • Membrane Separation • Selective Adsorpt ion Breakup by Procedure: • Donor/Automated Apheresis • Therapeutic Apheresis Report Segmentation Breakup by Application: • Renal Disorders • Hematological Disorders • Neurological Disorders • Autoimmune Disorders • Others Breakup by End User: • Blood Centers • Hospitals • Others Breakup by Region: Report • North America Segmentation • Asia-Pacifi c • Europe • Latin America • Middle East and Afr ica • Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation) • B. Braun SE • Charles River Laboratories International Inc. Competitive • Fresenius Medical Care AG & Co. KGaA • Haemonetics Corporation Landscape • Haier Biomedical with Key • Kaneka Corporation Players • Medica S.p.a. • Miltenyi Biotec • Nikkiso Co. Ltd. • Sb-Kawasumi Laboratories Inc. (Sumitomo Bakel ite Company Limited) • Terumo Bct Inc. (Terumo Corporation). What was the size of the global apheresis market in 2023? What is the expected growth rate of the global apheresis market during 2024-2032? Key What are the key factors driving the global apheresis market? Questions Answered in What has been the impact of COVID-19 on the global apheresis market? the Report What is the breakup of the global apheresis market based on the component? What is the breakup of the global apheresis market based on the product? What is the breakup of the global apheresis market based on the technology? What is the breakup of the global apheresis market based on procedure? What is the breakup of the global apheresis market based on the application? Key What is the breakup of the global apheresis market based on the end user? Questions Answered in What are the key regions in the global apheresis market? the Report Who are the key players/companies in the global apheresis market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l A p h e r e s i s M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y C o m p o n e n t 6 . 1 P l a s m a ( P l a s m a p h e r e s i s ) 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 P l a t e l e t s ( P l a t e l e t p h e r e s i s ) 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 L e u k o c y t e s ( L e u k a p h e r e s i s o r L e u k o p h e r e s i s ) 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 L y m p h o c y t e s ( L y m p h o p h e r e s i s o r L y m p h a p h e r e s i s ) 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 6 . 5 R B C ' s ( E r y t h r o p h e r e s i s ) 6 . 5 . 1 M a r k e t T r e n d s 6 . 5 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y P r o d u c t 7 . 1 D e v i c e s 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 D i s p o s a b l e s a n d R e a g e n t s 7 . 2 . 1 M a r k e t T r e n d s Table of 7 . 2 . 2 M a r k e t F o r e c a s t 7 . 3 S o f t w a r e 7 . 3 . 1 M a r k e t T r e n d s Contents 7 . 3 . 2 M a r k e t F o r e c a s t8 M a r k e t B r e a k u p b y T e c h n o l o g y 8 . 1 C e n t r i f u g a t i o n 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t 8 . 2 M e m b r a n e S e p a r a t i o n 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 S e l e c t i v e A d s o r p t i o n 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t 9 M a r k e t B r e a k u p b y P r o c e d u r e 9 . 1 D o n o r / A u t o m a t e d A p h e r e s i s 9 . 1 . 1 M a r k e t T r e n d s 9 . 1 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : h t t p s : / / w w w. im a rcg ro u p . co m / a ph e res i s - m a r ke t / t o c Partial List of Clients Partial List of Clients Disclaimer © 2024 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com +1-631-791-1145 [email protected] Stay With Us: